van Noorden S, Falkmer S. Gut-islet endocrinology - some evolutionary aspects. Invest Cell Pathol 1980; 3:21-35.

PubMed  Google Scholar 

Singh S, Asa SL, Dey C et al. Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus. Cancer Treat Rev 2016; 47:32-45.

Article  PubMed  Google Scholar 

Bellizzi AM. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. Histopathology 2020; 76(2):251-264.

Article  PubMed  Google Scholar 

Hoskoppal D, Epstein JI, Gown AM et al. SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. Histopathology 2020; 76(4):550-559.

Article  PubMed  Google Scholar 

Asa SL, Arkun K, Tischler AS et al. Middle Ear "Adenoma": a Neuroendocrine Tumor with Predominant L Cell Differentiation. Endocr Pathol 2021; 32(4):433-441.

Article  PubMed  CAS  Google Scholar 

Asa SL, Mete O, Schuller U, Ramani B, Mirchia K, Perry A. Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin. Am J Surg Pathol 2023; 47(4):469-475.

Article  PubMed  Google Scholar 

Asa SL, Mete O, Cusimano MD et al. Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Mod Pathol 2021; 34(9):1634-1650.

Article  PubMed  Google Scholar 

Lee SH, Kim BC, Chang HJ et al. Rectal neuroendocrine and L-cell tumors: diagnostic dilemma and therapeutic strategy. Am J Surg Pathol 2013; 37(7):1044-1052.

Article  PubMed  Google Scholar 

Sohn JH, Cho MY, Park Y et al. Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters. Cancer Res Treat 2015; 47(4):813-822.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim JY, Kim KS, Kim KJ et al. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis. Am J Surg Pathol 2015; 39(5):632-643.

Article  PubMed  Google Scholar 

Mete O, Dodington DW, Shen DL, Asa SL. The Clinicopathological Significance of Tumor Cell Subtyping in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors. Endocr Pathol 2024; 35(2):107-112.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Moser E, Ura A, Vogel L et al. ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and Outcome. Mod Pathol 2024; 37(11):100595.

Article  PubMed  CAS  Google Scholar 

Vanoli A, La Rosa S, Klersy C et al. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases. Neuroendocrinology 2017; 104(2):112-125.

Article  PubMed  CAS  Google Scholar 

Hermann G, Konukiewitz B, Schmitt A, Perren A, Kloppel G. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2. Virchows Arch 2011; 459(2):147-154.

Article  PubMed  CAS  Google Scholar 

Rosentraeger MJ, Garbrecht N, Anlauf M et al. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior. Virchows Arch 2016; 468(3):277-287.

Article  PubMed  Google Scholar 

Vanoli A, Albarello L, Uncini S et al. Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs. Am J Surg Pathol 2019; 43(6):725-736.

Article  PubMed  Google Scholar 

Nose V, Gill A, Teijeiro JMC, Perren A, Erickson L. Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes. Endocr Pathol 2022; 33(1):197-227.

Article  PubMed  Google Scholar 

Garbrecht N, Anlauf M, Schmitt A et al. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocr Relat Cancer 2008; 15(1):229-241.

Article  PubMed  Google Scholar 

Kim JA, Choi WH, Kim CN, Moon YS, Chang SH, Lee HR. Duodenal somatostatinoma: a case report and review. Korean J Intern Med 2011; 26(1):103-107.

Article  PubMed  PubMed Central  Google Scholar 

Rindi G, Mete O, Uccella S et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol 2022; 33(1):115-154.

Article  PubMed  CAS  Google Scholar 

Okubo Y, Yoshioka E, Suzuki M et al. Diagnosis, Pathological Findings, and Clinical Management of Gangliocytic Paraganglioma: A Systematic Review. Front Oncol 2018; 8:291.

Article  PubMed  PubMed Central  Google Scholar 

Asa SL, Uccella S, Tischler A. The Unique Importance of Differentiation and Function in Endocrine Neoplasia. Endocr Pathol 2023; 34(4):382-392.

Article  PubMed  CAS  Google Scholar 

Asa SL, Mohamed A. Pancreatic and Ileal Neuroendocrine Tumors: Metastatic Disease or a Novel MEN Syndrome? Am J Surg Pathol 2024.

Dohrmann C, Gruss P, Lemaire L. Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas. Mech Dev 2000; 92(1):47-54.

Article  PubMed  CAS  Google Scholar 

van der Meulen T, Huising MO. Role of transcription factors in the transdifferentiation of pancreatic islet cells. J Mol Endocrinol 2015; 54(2):R103-R117.

Article  PubMed  PubMed Central  Google Scholar 

Watanabe K, Hasegawa H, Sakuma H, Tsuboi M, Ito S, Suzuki T. Two cases of duodenal gangliocytic paraganglioma: immunocytochemical characteristics. Fukushima J Med Sci 1995; 41(2):141-152.

PubMed  CAS  Google Scholar 

Lutz F, Hornburg SM, Moller K et al. PAX6 is a useful marker for pancreatic origin of neuroendocrine neoplasms: A tissue microarray study evaluating more than 19,000 tumors from 150 different tumor types. Hum Pathol 2024; 154:105695.

Article  PubMed  CAS  Google Scholar 

Larsson LI, St-Onge L, Hougaard DM, Sosa-Pineda B, Gruss P. Pax 4 and 6 regulate gastrointestinal endocrine cell development. Mech Dev 1998; 79(1-2):153-159.

Article  PubMed  CAS  Google Scholar 

Du A, McCracken KW, Walp ER et al. Arx is required for normal enteroendocrine cell development in mice and humans. Dev Biol 2012; 365(1):175-188.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Beucher A, Gjernes E, Collin C et al. The homeodomain-containing transcription factors Arx and Pax4 control enteroendocrine subtype specification in mice. PLoS ONE 2012; 7(5):e36449.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hackeng WM, Morsink FHM, Moons LMG et al. Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration. Diagn Cytopathol 2020; 48(4):308-315.

Article  PubMed  Google Scholar 

Hackeng WM, Schelhaas W, Morsink FHM et al. Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas. Endocr Pathol 2020; 31(2):108-118.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ciobanu OA, Martin SC, Herlea V, Fica S. Insights into Epigenetic Changes Related to Genetic Variants and Cells-of-Origin of Pancreatic Neuroendocrine Tumors: An Algorithm for Practical Workup. Cancers (Basel) 2022; 14(18).

Hackeng WM, Brosens LAA, Kim JY et al. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size. Gut 2022; 71(5):961-973.

Article